האגודה הישראלית להיפנוזה והמכללה האקדמית תל-אביב-יפו מזמינות לסמינר של מרצה-אורח פרופ' אירווין קירש (בריטניה, ארה''ב) בנושא: Master-Class: Hypnosis, Placebo and the Power of Suggestion Depending on the condition being treated, the placebo effect can be powerful and long-lasting. The response to antidepressants, for example, is largely due to the placebo effect. Although many doctors admit to giving placebos to patients, medical associations argue that this is an unethical practice, because it involves deceiving patients. I will explore the empirical evidence supporting three options for non-deceptive use of the placebo in clinical practice: 1) methods of enhancing the placebo component of active treatments, 2) the use of ‘open-label’ placebos, and 3) hypnosis. If nothing else, hypnosis can be thought of as a non-deceptive placebo. Recent neuroimaging data has shed light on the state of consciousness produced by hypnotic inductions. They confirm that even the most rare hypnotic responses can be produced without the induction of hypnosis and also that inductions can enhance responsiveness to suggestion. Translations to clinical practice are explored. הסמינר יתקיים ביום רביעי על מנת להירשם 15.2.12 יש לשלוח המחאה על סך 100 ש" ח על שם " האגודה הישראלית להיפנוזה" בין השעות 16:00 – 20:00 לכתובת ה: אגודה הישראלית להיפנוזה במכללה האקדמית תל אביב – יפו ת.ד. 14044תל אביב 61140 אולם 007 בניין וסטון למדעי המחשב (בקומת הכניסה). טל. 03-6320573 נ א לצרף בנוסף שם מלא ומספר טלפון לשאלות אתם יכולים להתקשר ולהשאיר פרטים בטלפון 052-2533239 Irving Kirsch is Associate Director of the Program in Placebo Studies at the Harvard Medical School, lecturer in medicine at Beth Israel Deaconess Medical Center, Professor of Psychology at the University of Plymouth (UK), and Professor Emeritus at the University of Hull and the University of Connecticut. He has published 10 books and more than 200 scientific journal articles and book chapters on placebo effects, antidepressant medication, hypnosis, and suggestion. He originated the concept of response expectancy. His meta-analyses on the efficacy of antidepressants were covered extensively in the international media and influenced official guidelines for the treatment of depression in the United Kingdom. His book, The Emperor’s New Drugs: Exploding the Antidepressant Myth , which has been published in English, French, and Japanese, was shortlisted for the prestigious Mind Book of the Year award. It was the topic of a 5- page cover story in Newsweek, and was favorably reviewed in the New York Review of Books by Marcia Angell, former editor-in-chief of the New England Journal of Medicine .